Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
SterileCare, Inc. has 2 pending office actions in Biotechnology & Pharmaceuticals. The record identifies 2 distinct examiners and 2 distinct art units, so the matters require attention across separate examination channels.
ARMSTRONG, SUSANNAH SIPPLE is the busiest examiner, with 1 pending matter. Counsel can coordinate the overall biotechnology strategy while tailoring claim amendments and evidence to each individual prosecution record.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ARMSTRONG, SUSANNAH SIPPLE | 1 | 30.0% | +53.1% |
| MEDWAY, SCOTT J | 1 | 66.6% | +23.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18112674 | COMPOSITIONS OF EDTA HAVING ACTIVITY AGAINST PLANKTONIC AND BIOFILM CELLS OF CLINICALLY RELEVANT PATHOGENS | ARMSTRONG, SUSANNAH SIPPLE | 4d overdue |
| 18112648 | DISINFECTING CAP KIT FOR LUER ACCESS DEVICES | MEDWAY, SCOTT J | 35d |
| Art Unit | Apps |
|---|---|
| 1616 | 1 |
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18112674 | COMPOSITIONS OF EDTA HAVING ACTIVITY AGAINST PLANKTONIC AND BIOFILM CELLS OF CLINICALLY RELEVANT PATHOGENS | ARMSTRONG, SUSANNAH SIPPLE | 1616 | §103 | Final Rejection | 4d overdue | Pending | Feb 22, 2023 |
| 18112648 | DISINFECTING CAP KIT FOR LUER ACCESS DEVICES | MEDWAY, SCOTT J | 3783 | §103 | Non-Final OA | 35d | Pending | Feb 22, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSterileCare, Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Susannah Sipple Armstrong has the most, with 1 of SterileCare, Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
